Stock Events

Stock Events

Search...

Allogene Therapeutics (ALLO) Q4 2023 Earnings

14MarConfirmed

Q1 2023

Q2 2023

Q3 2023

Q4 2023

-0.68

-0.58

-0.47

-0.37

Details

Expected EPS

-0.450778

Actual EPS

-0.51

Surprise EPS

-0.06

Surprise Percent

+13.14%

Description

Allogene Therapeutics (ALLO) has reported earnings of -0.51 per share for Q4 2023.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.